Paul Tudor Jones Deciphera Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 39,525 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,525Holding current value
$0% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding DCPH
# of Institutions
178Shares Held
59.6MCall Options Held
5.3KPut Options Held
27.6K-
Black Rock Inc. New York, NY5.99MShares$00.0% of portfolio
-
Armistice Capital, LLC New York, NY5.9MShares$01.26% of portfolio
-
Redmile Group, LLC San Francisco, CA5.3MShares$03.28% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.13MShares$01.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...